Others Products Targets
- STAT (10)
- JAK (10)
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- NFKB and IKB (30)
- Toll-like Receptor (11)
- TGF-β Receptor (9)
- STING-Dependent Signaling (1)
- NFAT (5)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Integrin Receptor (15)
- Inflammasomes (1)
- Others (16)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- Complement (2)
- IRAK (1)
- Antiviral (36)
- Histamine H4 Receptor (12)
- Histamine H3 Receptor (22)
- Histamine H2 Receptor (10)
- Histamine H1 Receptor (17)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Adenosine A3 Receptor (8)
- Adenosine A1 Receptor (12)
- Janus N-terminal Kinase (12)
- AP-1 (2)
- Purinergic (P2Y) Receptor (31)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
- Cytokine (15)
- Platelet-Activating Factor (PAF) Receptor (5)
Products for Others - Page 18
- Cat.No. Product Name Information/Activity
-
BCC6985
NF 023
104869-31-0
-
BCC7404
NF 110
111150-22-2
-
BCC7367
NF 157
NF157 is a highly selective nanomolar P2Y11 antagonist with a pKi of 7.35. The IC50s are 463 nM, 1811 µM, 170 µM for P2Y11 (Ki=44.3 nM), P2Y1 (Ki=187 µM), P2Y2 (Ki=28.9 µM), respectively. NF157, significantly reduces expression of metalloproteinase (MMP)-3, MMP-13, can be used in the treatment of osteoarthritis (OA).
-
BCC6964
NF 279
202983-32-2
-
BCC7043
NF 449
Highly selective P2X<sub>1</sub> antagonist
-
BCC6725
PPADS tetrasodium salt
PPADS tetrasodiuma is a non-selective P2X receptor antagonist. PPADS tetrasodiuma blocks recombinant P2X1, -2, -3, -5 with IC50s ranging from 1 to 2.6 μM. PPADS tetrasodiuma blocks native P2Y2-like (IC50~0.9 mM) and recombinant P2Y4 (IC50~15 mM) receptors. PPADS tetrasodiuma is an inhibitor of the reverse mode of the Na/Ca²⁺exchanger in guinea pig airway smooth muscle.
-
BCC6749
iso-PPADS tetrasodium salt
P2X antagonist
-
BCC7015
PPNDS
1021868-77-8
-
BCC7276
Ro 0437626
134362-79-1
-
BCC6157
Ro 51
1050670-85-3


